Contact this trialFirst, we need to learn more about you.
PI3K inhibitor
Copanlisib + Ibrutinib for Central Nervous System Lymphoma
Recruiting1 awardPhase 1 & 2
Basking Ridge, New Jersey
This trial is testing if it's safe to use two drugs, copanlisib and ibrutinib, together to treat people with a brain cancer called PCNSL.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.